Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 169 citing Hui: Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1–positive.... (0.09 sec) 

Biological actions and therapeutic potential of the glucagon-like peptides

- glucagon.com [PDF] 
DJ Drucker - Gastroenterology, 2002 - Elsevier
The glucagon-like peptides (GLP-1 and GLP-2) are proglucagon-derived peptides
cosecreted from gut endocrine cells in response to nutrient ingestion. GLP-1
acts as an incretin to lower blood glucose via stimulation of insulin ...
Cited by 252 - Related articles - BL Direct - All 13 versions

Glucagon-like peptide-1 receptor signaling modulates β cell apoptosis

- glucagon.com [PDF] 
Y Li, T Hansotia, B Yusta, F Ris, PA Halban, … - Journal of Biological Chemistry, 2003 - ASBMB
Glucagon-like peptide-1 (GLP-1) stimulates insulin secretion and augments β
cell mass via activation of β cell proliferation and islet neogenesis. We
examined whether GLP-1 receptor signaling modifies the cellular ...
Cited by 252 - Related articles - BL Direct - All 7 versions

Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet- …

- endojournals.org
EJ Abraham, CA Leech, JC Lin, H Zulewski, … - Endocrinology, 2002 - Endocrine Soc
Glucagon-like peptide-1 (GLP-1) is an intestinal incretin hormone, derived from
the processing of proglucagon, that exerts insulinotropic actions on
insulin-producing pancreatic islet ß-cells. Recently GLP-1 was shown to ...
Cited by 236 - Related articles - BL Direct - All 4 versions

Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis

- endojournals.org
DJ Drucker - Molecular Endocrinology, 2003 - Endocrine Soc
Peptide hormones are secreted from endocrine cells and neurons and exert their
actions through activation of G protein-coupled receptors to regulate a diverse
number of physiological systems including control of energy homeostasis, ...
Cited by 227 - Related articles - BL Direct - All 8 versions

In vivo and in vitro characterization of insulin-producing cells obtained from murine bone …

- tamu-commerce.edu [PDF] 
DQ Tang, LZ Cao, BR Burkhardt, CQ Xia, SA … - Diabetes, 2004 - Am Diabetes Assoc
Efforts toward routine islet cell transplantation as a means for reversing type
1 diabetes have been hampered by islet availability as well as allograft
rejection. In vitro transdifferentiation of mouse bone marrow (BM)-derived ...
Cited by 212 - Related articles - BL Direct - All 7 versions

Dipeptidyl peptidase IV inhibitor treatment stimulates β-cell survival and islet neogenesis in …

- diabetesjournals.org
JA Pospisilik, J Martin, T Doty, JA Ehses, N … - Diabetes, 2003 - Am Diabetes Assoc
Recent studies into the physiology of the incretins glucose-dependent
insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) have added
stimulation of β-cell growth, differentiation, and cell survival to well- ...
Cited by 161 - Related articles - BL Direct - All 4 versions

Glucose-Dependent Insulinotropic Polypeptide Is a Growth Factor for {beta}(INS-1) Cells by …

- endojournals.org
A Trumper, K Trumper, H Trusheim, R Arnold, … - Molecular Endocrinology, 2001 - Endocrine Soc
Activation of the G-protein-coupled receptor for glucose-dependent
insulinotropic polypeptide facilitates insulin-release from pancreatic ß-cells.
In the present study, we examined whether glucose-dependent insulinotropic ...
Cited by 156 - Related articles - BL Direct - All 3 versions

Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained …


JA Pospisilik, SG Stafford, HU Demuth, R … - Diabetes, 2002 - Am Diabetes Assoc
The incretins, glucose-dependent insulinotropic polypeptide (GIP) and
glucagon-like peptide 1 (GLP-1) are responsible for >50% of nutrient-stimulated
insulin secretion. After being released into the circulation, GIP and GLP-1 ...
Cited by 135 - Related articles - BL Direct - All 6 versions

Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes


DJ Drucker - eid, 2003 - informahealthcare.com
Incretins are peptide hormones, exemplified by glucose-dependent insulino-
tropic peptide and glucagon-like peptide 1 that are released from the gut in
response to nutrient ingestion and enhance glucose-stimulated insulin ...
Cited by 118 - Related articles - All 6 versions

Regulation of pancreatic beta-cell mass

- physiology.org
L Bouwens, I Rooman - Physiological reviews, 2005 - Am Physiological Soc
Beta-cell mass regulation represents a critical issue for understanding
diabetes, a disease characterized by a near-absolute (type 1) or relative (type
2) deficiency in the number of pancreatic beta cells. The number of islet ...
Cited by 115 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google